Jennifer Danielsson1, Joy Vink2, Shunsuke Hyuga1, Xiao Wen Fu1, Hiromi Funayama3, Ronald Wapner2, Andrew M Blanks4, George Gallos1. 1. 1 Department of Anesthesiology, Columbia University Medical Center, Columbia University College of Physicians and Surgeons, New York, NY, USA. 2. 2 Department of Obstetrics and Gynecology, Columbia University Medical Center, Columbia University College of Physicians and Surgeons, New York, NY, USA. 3. 3 Department of Pediatric Dentistry, Tsurumi University School of Dental Medicine, Yokohama, Japan. 4. 4 Cell and Developmental Biology, Division of Biomedical Sciences, Warwick Medical School, University of Warwick, Coventry, United Kingdom.
Abstract
BACKGROUND: Spontaneous preterm labor leading to preterm birth is a significant obstetric problem leading to neonatal morbidity and mortality. Current tocolytics are not completely effective and novel targets may afford a therapeutic benefit. OBJECTIVE: To determine whether the anoctamin (ANO) family, including the calcium-activated chloride channel ANO1, is present in pregnant human uterine smooth muscle (USM) and whether pharmacological and genetic modulation of ANO1 modulates USM contraction. METHODS: Reverse transcription-polymerase chain reaction (RT-PCR), quantitative RT-PCR, and immunohistochemical staining were done to determine which members of the ANO family are expressed in human USM. Uterine smooth muscle strips were studied in an organ bath to determine whether ANO1 antagonists inhibit oxytocin-induced USM contractions. Anoctamin 1 small interfering RNA (siRNA) knockdown was performed to determine its effect on filamentous-/globular (F/G)-actin ratio, a measurement of actin polymerization's role in promoting smooth muscle contraction. RESULTS: Messenger RNA (mRNA) encoding all members of the ANO family (except ANO7) are expressed in pregnant USM tissue. Anoctamin 1 mRNA expression was decreased 15.2-fold in pregnant USM compared to nonpregnant. Anoctamin 1 protein is expressed in pregnant human USM tissue. Functional organ bath studies with pregnant human USM tissue demonstrated that the ANO1 antagonist benzbromarone attenuates the force and frequency of oxytocin-induced contractions. In human USM cells, siRNA knockdown of ANO1 decreases F-/G-actin ratios. CONCLUSION: Multiple members of the ANO family, including the calcium-activated chloride channel ANO1, are expressed in human USM. Antagonism of ANO1 by pharmacological inhibition and genetic knockdown leads to an attenuation of contraction in pregnant human USM. Anoctamin 1 is a potentially novel target for tocolysis.
BACKGROUND: Spontaneous preterm labor leading to preterm birth is a significant obstetric problem leading to neonatal morbidity and mortality. Current tocolytics are not completely effective and novel targets may afford a therapeutic benefit. OBJECTIVE: To determine whether the anoctamin (ANO) family, including the calcium-activated chloride channel ANO1, is present in pregnant human uterine smooth muscle (USM) and whether pharmacological and genetic modulation of ANO1 modulates USM contraction. METHODS: Reverse transcription-polymerase chain reaction (RT-PCR), quantitative RT-PCR, and immunohistochemical staining were done to determine which members of the ANO family are expressed in human USM. Uterine smooth muscle strips were studied in an organ bath to determine whether ANO1 antagonists inhibit oxytocin-induced USM contractions. Anoctamin 1 small interfering RNA (siRNA) knockdown was performed to determine its effect on filamentous-/globular (F/G)-actin ratio, a measurement of actin polymerization's role in promoting smooth muscle contraction. RESULTS: Messenger RNA (mRNA) encoding all members of the ANO family (except ANO7) are expressed in pregnant USM tissue. Anoctamin 1 mRNA expression was decreased 15.2-fold in pregnant USM compared to nonpregnant. Anoctamin 1 protein is expressed in pregnant human USM tissue. Functional organ bath studies with pregnant human USM tissue demonstrated that the ANO1 antagonist benzbromarone attenuates the force and frequency of oxytocin-induced contractions. In human USM cells, siRNA knockdown of ANO1 decreases F-/G-actin ratios. CONCLUSION: Multiple members of the ANO family, including the calcium-activated chloride channel ANO1, are expressed in human USM. Antagonism of ANO1 by pharmacological inhibition and genetic knockdown leads to an attenuation of contraction in pregnant human USM. Anoctamin 1 is a potentially novel target for tocolysis.
Authors: Carol A Hirshman; Defen Zhu; Thomas Pertel; Reynold A Panettieri; Charles W Emala Journal: Am J Physiol Lung Cell Mol Physiol Date: 2005-05 Impact factor: 5.464
Authors: Sara A Carney; Hidetoshi Tahara; Carol D Swartz; John I Risinger; Hong He; Alicia B Moore; Joseph K Haseman; J Carl Barrett; Darlene Dixon Journal: Lab Invest Date: 2002-06 Impact factor: 5.662
Authors: Anatoly Shmygol; Andrew M Blanks; Gilles Bru-Mercier; Joanna E Gullam; Steven Thornton Journal: Ann N Y Acad Sci Date: 2007-03-01 Impact factor: 5.691
Authors: Jennifer Danielsson; Aisha S Kuforiji; Gene T Yocum; Yi Zhang; Dingbang Xu; George Gallos; Charles W Emala Journal: Am J Physiol Lung Cell Mol Physiol Date: 2019-11-20 Impact factor: 5.464
Authors: Joy Vink; Victoria Yu; Sudip Dahal; James Lohner; Conrad Stern-Asher; Mirella Mourad; George Davis; Zenghui Xue; Shuang Wang; Kristin Myers; Jan Kitajewski; Xiaowei Chen; Ronald J Wapner; Cande V Ananth; Michael Sheetz; George Gallos Journal: Reprod Sci Date: 2020-07-22 Impact factor: 2.924
Authors: Shunsuke Hyuga; Robert C Parry; Jennifer Danielsson; Joy Vink; Xiao Wen Fu; Amy Wu; William Dan; Peter D Yim; George Gallos Journal: J Physiol Sci Date: 2021-02-22 Impact factor: 2.257